Literature DB >> 4350802

Antiviral activity of isoprinosine in vitro and in vivo.

T W Chang, L Weinstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4350802     DOI: 10.1097/00000441-197302000-00005

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


× No keyword cloud information.
  10 in total

1.  Evaluation of isoprinosine in experimental human rhinovirus infection.

Authors:  D M Pachuta; Y Togo; R B Hornick; A R Schwartz; S Tominaga
Journal:  Antimicrob Agents Chemother       Date:  1974-04       Impact factor: 5.191

2.  Suppression of frequently recurring genital herpes: acyclovir v inosine pranobex.

Authors:  A Mindel; O Carney; C Sonnex; M Freris; G Patou; P Williams
Journal:  Genitourin Med       Date:  1989-04

3.  Variables influencing the in vitro susceptibilities of herpes simplex viruses to antiviral drugs.

Authors:  M I Marks
Journal:  Antimicrob Agents Chemother       Date:  1974-07       Impact factor: 5.191

Review 4.  Ribavirin and inosiplex: a review of their present status in viral diseases.

Authors:  T W Chang; R C Heel
Journal:  Drugs       Date:  1981-08       Impact factor: 9.546

5.  Isoprinosine in classical acute viral hepatitis.

Authors:  K C Lam; H J Lin; C L Lai; S K Lam; Y L Kwan
Journal:  Am J Dig Dis       Date:  1978-10

6.  Anti-herpesvirus action of isoprinosine.

Authors:  P Gordon; B Ronsen; E R Brown
Journal:  Antimicrob Agents Chemother       Date:  1974-02       Impact factor: 5.191

7.  Plaque inhibition assay for drug susceptibility testing of influenza viruses.

Authors:  F G Hayden; K M Cote; R G Douglas
Journal:  Antimicrob Agents Chemother       Date:  1980-05       Impact factor: 5.191

Review 8.  Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  D M Campoli-Richards; E M Sorkin; R C Heel
Journal:  Drugs       Date:  1986-11       Impact factor: 9.546

Review 9.  Inosine Pranobex Deserves Attention as a Potential Immunomodulator to Achieve Early Alteration of the COVID-19 Disease Course.

Authors:  Jiří Beran; Marián Špajdel; Jiří Slíva
Journal:  Viruses       Date:  2021-11-09       Impact factor: 5.048

Review 10.  Repurposing an In Vitro Measles Virus Dissemination Assay for Screening of Antiviral Compounds.

Authors:  Katharina S Schmitz; Mona V Lange; Lennert Gommers; Kim Handrejk; Danielle P Porter; Christopher A Alabi; Anne Moscona; Matteo Porotto; Rory D de Vries; Rik L de Swart
Journal:  Viruses       Date:  2022-05-29       Impact factor: 5.818

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.